Robert Hermann, German clinical pharmacologist, researcher. Fellow: American College Clinical Pharmacology; member: German Society Clinical Pharmacology and Therapeutics, German Society Experimental and Clinical Pharmacology & Toxicology, Association Applied Human Pharmacology (board member 1991-1994).
Resident in anaesthesiology Institute Anaesthesiology & Surgical Intensive Care Medicine, City Clinic Hanau, Germany, 1982—1985. Research assistant anaesthesiology Center Anaesthesiology & Resuscitation, Clinic of Johann-Wolfgang-Goethe University, 1985—1987, instructor anaesthesiology, 1988—1990. Medical advisor, department clinical pharmacology American Seed Trade Association Medica AG, 1990—1991, director clinical pharmacology, 1991—2000, director clinical Research and Development respiration & allergy, 2000—2001.
Vice president clinical Research and Development VIATRIS GmbH & Company KG, 2001—2003. Head clinical pharmacology ALTANA Pharma AG, Konstanz, Germany, 2003—2006, corporation director exploratory medicine, 2006—2007. Chief medical officer AiCuris GmbH & Company KG, Wuppertal, Germany, since 2007.
Managing director Clinical Research Appliance, Radolfiell, Germany, 2008. Member, co-chair, chair board trustees Fraunhofer Institute Toxicology & Experimental Medicine, Hannover, Niedersachsen, Germany, 2000—2008.
- Achievements include patents for medical use of the selective neuronal potassium channel opener retigabine in novel indications. Patents for the combined use of the soft-corticosteroid loteprednol and PDE4i inhibitors for the use in chronic inflammatory airway diseases. Patents for the combination of a potassium channel opener with a sodium channel antagonist for the treatment of musculo-scelettal pain.
1982 - 1985
1985 - 1987
1990 - 1991
2001 - 2003
2003 - 2006
- show more ...